AAAAAA

   
Results: 1-25 | 26-49
Results: 1-25/49
BCL-2 ACCELERATES THE MATURATION OF EARLY SENSORY NEURONS
Authors: MIDDLETON G PINON LGP WYATT S DAVIES AM
Citation: G. Middleton et al., BCL-2 ACCELERATES THE MATURATION OF EARLY SENSORY NEURONS, The Journal of neuroscience, 18(9), 1998, pp. 3344-3350
GERARD-V.-MIDDLETON-DISTINGUISHED-EDUCATOR-AWARD - RESPONSE
Authors: MIDDLETON G
Citation: G. Middleton, GERARD-V.-MIDDLETON-DISTINGUISHED-EDUCATOR-AWARD - RESPONSE, AAPG bulletin, 82(6), 1998, pp. 1256-1256
THE PREVALENCE AND AGE DISTRIBUTION OF HUMAN THYMIC B-LYMPHOID FOLLICLES
Authors: MIDDLETON G SCHOCH EM
Citation: G. Middleton et Em. Schoch, THE PREVALENCE AND AGE DISTRIBUTION OF HUMAN THYMIC B-LYMPHOID FOLLICLES, Pathology, 30(2), 1998, pp. 160-163
T1-WEIGHTED MAGNETIC-RESONANCE-IMAGING IN BREAST-CANCER VERTEBRAL METASTASES - CHANGES ON TREATMENT AND CORRELATION WITH RESPONSE TO THERAPY
Authors: BROWN AL MIDDLETON G MACVICAR AD HUSBAND JES
Citation: Al. Brown et al., T1-WEIGHTED MAGNETIC-RESONANCE-IMAGING IN BREAST-CANCER VERTEBRAL METASTASES - CHANGES ON TREATMENT AND CORRELATION WITH RESPONSE TO THERAPY, Clinical Radiology, 53(7), 1998, pp. 493-501
CLINICAL BENEFIT FROM PALLIATIVE CHEMOTHERAPY IN NONSMALL CELL LUNG-CANCER EXTENDS TO THE ELDERLY AND THOSE WITH POOR PROGNOSTIC FACTORS
Authors: HICKISH TF SMITH IE OBRIEN MER ASHLEY S MIDDLETON G
Citation: Tf. Hickish et al., CLINICAL BENEFIT FROM PALLIATIVE CHEMOTHERAPY IN NONSMALL CELL LUNG-CANCER EXTENDS TO THE ELDERLY AND THOSE WITH POOR PROGNOSTIC FACTORS, British Journal of Cancer, 78(1), 1998, pp. 28-33
BCL-2 INFLUENCES AXONAL GROWTH-RATE IN EMBRYONIC SENSORY NEURONS
Authors: HILTON M MIDDLETON G DAVIES AM
Citation: M. Hilton et al., BCL-2 INFLUENCES AXONAL GROWTH-RATE IN EMBRYONIC SENSORY NEURONS, Current biology, 7(10), 1997, pp. 798-800
PHASE-I STUDY OF THE BIODISTRIBUTION, PHARMACOKINETICS AND IMMUNOGENICITY OF IN-111-HCTMO1 (CDP671)+ - PREDOSING WITH UNLABELED HCTMO1 IN PATIENTS (PTS) WITH LUNG-CANCER/
Authors: VERRILL M MIDDLETON G PRIEST K SPENCER L CHITTENDEN S MCCREADY R COX N SKELTON L OBRIEN M SMITH I
Citation: M. Verrill et al., PHASE-I STUDY OF THE BIODISTRIBUTION, PHARMACOKINETICS AND IMMUNOGENICITY OF IN-111-HCTMO1 (CDP671)+ - PREDOSING WITH UNLABELED HCTMO1 IN PATIENTS (PTS) WITH LUNG-CANCER/, European journal of cancer, 33, 1997, pp. 1114-1114
BCL-2 IS REQUIRED FOR CRANIAL SENSORY NEURON SURVIVAL AT DEFINED STAGES OF EMBRYONIC-DEVELOPMENT
Authors: PINON LGP MIDDLETON G DAVIES AM
Citation: Lgp. Pinon et al., BCL-2 IS REQUIRED FOR CRANIAL SENSORY NEURON SURVIVAL AT DEFINED STAGES OF EMBRYONIC-DEVELOPMENT, Development, 124(20), 1997, pp. 4173-4178
EARLY IDENTIFICATION OF PATIENTS AT RISK OF DEATH DUE TO INFECTIONS, HEMORRHAGE, OR GRAFT FAILURE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION ON THE BASIS OF THE LEUKOCYTE COUNTS
Authors: MEHTA J POWLES R SINGHAL S HORTON C MIDDLETON G EISEN T MELLER S PINKERTON CR TRELEAVEN J
Citation: J. Mehta et al., EARLY IDENTIFICATION OF PATIENTS AT RISK OF DEATH DUE TO INFECTIONS, HEMORRHAGE, OR GRAFT FAILURE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION ON THE BASIS OF THE LEUKOCYTE COUNTS, Bone marrow transplantation, 19(4), 1997, pp. 349-355
THE INTERNATIONAL STROKE TRIAL (IST) - A RANDOMIZED TRIAL OF ASPIRIN,SUBCUTANEOUS HEPARIN, BOTH, OR NEITHER AMONG 19 435 PATIENTS WITH ACUTE ISCHEMIC STROKE
Authors: SANDERCOCK P COLLINS R COUNSELL C FARRELL B PETO R SLATTERY J WARLOW C ANDERSON S BOWIE A BOYLE J BROWNLIE A CHARLTON D CRANSWICK G DAY L DENNIS M DORMAN P FRASER H KAYE M LINDLEY R LIU M MACDONALD C MCCRINDLE I MIDDLETON G PERRY D SCOLTOCK V SMITH B TAYLOR H WADDELL F WARDLAW J CROWTHER J HEINEMAN J KNIGHT S RADLEY A RIPLEY R RICHARDS S WILBERFORCE S CHEN ZM VANGIJN J HARRISON M WILHELMSEN L
Citation: P. Sandercock et al., THE INTERNATIONAL STROKE TRIAL (IST) - A RANDOMIZED TRIAL OF ASPIRIN,SUBCUTANEOUS HEPARIN, BOTH, OR NEITHER AMONG 19 435 PATIENTS WITH ACUTE ISCHEMIC STROKE, Lancet, 349(9065), 1997, pp. 1569-1581
THE ROLE OF THE BCL-2 FAMILY OF PROTEINS IN REGULATING NEURONAL SURVIVAL
Authors: DAVIES AM KORSMEYER S PINON L ADUL J MIDDLETON G
Citation: Am. Davies et al., THE ROLE OF THE BCL-2 FAMILY OF PROTEINS IN REGULATING NEURONAL SURVIVAL, British Journal of Pharmacology, 120, 1997, pp. 377-377
A COMPARISON OF VINCRISTINE AND DOXORUBICIN INFUSIONAL CHEMOTHERAPY WITH METHYLPREDNISOLONE (VAMP) WITH THE ADDITION OF WEEKLY CYCLOPHOSPHAMIDE (C-VAMP) AS INDUCTION TREATMENT FOLLOWED BY AUTOGRAFTING IN PREVIOUSLY UNTREATED MYELOMA
Authors: RAJE N POWLES R KULKARNI S MILAN S MIDDLETON G SINGHAL S MEHTA J MILLAR B VINER C RAYMOND J TRELEAVEN J CUNNINGHAM D GORE M
Citation: N. Raje et al., A COMPARISON OF VINCRISTINE AND DOXORUBICIN INFUSIONAL CHEMOTHERAPY WITH METHYLPREDNISOLONE (VAMP) WITH THE ADDITION OF WEEKLY CYCLOPHOSPHAMIDE (C-VAMP) AS INDUCTION TREATMENT FOLLOWED BY AUTOGRAFTING IN PREVIOUSLY UNTREATED MYELOMA, British Journal of Haematology, 97(1), 1997, pp. 153-160
COMPARISON OF MARROW VS BLOOD-DERIVED STEM-CELLS FOR AUTOGRAFTING IN PREVIOUSLY UNTREATED MULTIPLE-MYELOMA
Authors: RAJE N POWLES R HORTON C MILLAR B SHEPHERD V MIDDLETON G KULKARNI S EISEN T MEHTA J SINGHAL S TRELEAVEN J
Citation: N. Raje et al., COMPARISON OF MARROW VS BLOOD-DERIVED STEM-CELLS FOR AUTOGRAFTING IN PREVIOUSLY UNTREATED MULTIPLE-MYELOMA, British Journal of Cancer, 75(11), 1997, pp. 1684-1689
BAX PROMOTES NEURONAL SURVIVAL AND ANTAGONIZES THE SURVIVAL EFFECTS OF NEUROTROPHIC FACTORS
Authors: MIDDLETON G NUNEZ G DAVIES AM
Citation: G. Middleton et al., BAX PROMOTES NEURONAL SURVIVAL AND ANTAGONIZES THE SURVIVAL EFFECTS OF NEUROTROPHIC FACTORS, Development, 122(2), 1996, pp. 695-701
LONG-TERM FOLLOW-UP OF PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA IN FIRST COMPLETE REMISSION AFTER CYCLOPHOSPHAMIDE-TOTAL BODY IRRADIATION AND CYCLOSPORINE
Authors: MEHTA J POWLES R TRELEAVEN J HORTON C TAIT D MELLER S PINKERTON CR MIDDLETON G EISEN T SINGHAL S
Citation: J. Mehta et al., LONG-TERM FOLLOW-UP OF PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA IN FIRST COMPLETE REMISSION AFTER CYCLOPHOSPHAMIDE-TOTAL BODY IRRADIATION AND CYCLOSPORINE, Bone marrow transplantation, 18(4), 1996, pp. 741-746
T-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION FROM A PARTIALLY HLA-MISMATCHED UNRELATED DONOR FOR PROGRESSIVE CHRONIC LYMPHOCYTIC-LEUKEMIA AND FLUDARABINE-INDUCED BONE-MARROW FAILURE
Authors: MEHTA J POWLES R SINGHAL S MATTHEY F HAMBLIN M MIDDLETON G PRENDIVILLE J GLYNNE P ZOMAS A TRELEAVEN J CATOVSKY D
Citation: J. Mehta et al., T-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION FROM A PARTIALLY HLA-MISMATCHED UNRELATED DONOR FOR PROGRESSIVE CHRONIC LYMPHOCYTIC-LEUKEMIA AND FLUDARABINE-INDUCED BONE-MARROW FAILURE, Bone marrow transplantation, 17(5), 1996, pp. 881-883
MUTAGEN IN CIGARETTES AND FOGGY AIR
Authors: MIDDLETON G
Citation: G. Middleton, MUTAGEN IN CIGARETTES AND FOGGY AIR, Lancet, 348(9043), 1996, pp. 1744-1744
FACTORS AFFECTING ENGRAFTMENT AFTER UNPURGED AUTOGRAFTING IN ACUTE-LEUKEMIA
Authors: MIDDLETON G POWLES R SINGHAL S EISEN T TRELEAVEN J MEHTA J
Citation: G. Middleton et al., FACTORS AFFECTING ENGRAFTMENT AFTER UNPURGED AUTOGRAFTING IN ACUTE-LEUKEMIA, British Journal of Haematology, 93, 1996, pp. 168-168
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA AND PROLYMPHOCYTIC LEUKEMIA
Authors: MIDDLETON G MEHTA J POWLES R SINGHAL S SWANSBURY GJ TRELEAVEN J CATOVSKY D
Citation: G. Middleton et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA AND PROLYMPHOCYTIC LEUKEMIA, British Journal of Haematology, 93, 1996, pp. 169-169
IDARUBICIN HIGH-DOSE CYTARABINE AND ETOPOSIDE FOR REMISSION INDUCTIONIN PATIENTS WITH RELAPSED ACUTE-LEUKEMIA
Authors: EISEN T POWLES R SINGHAL S MIDDLETON G TRELEAVEN J MEHTA J
Citation: T. Eisen et al., IDARUBICIN HIGH-DOSE CYTARABINE AND ETOPOSIDE FOR REMISSION INDUCTIONIN PATIENTS WITH RELAPSED ACUTE-LEUKEMIA, British Journal of Haematology, 93, 1996, pp. 253-253
LONG-TERM FOLLOW-UP OF ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA IN FIRST REMISSION AFTER CYCLOPHOSPHAMIDE TOTAL-BODY IRRADIATION AND CYCLOSPORINE
Authors: EISEN T POWLES R SINGHAL S MIDDLETON G TRELEAVEN J MEHTA J
Citation: T. Eisen et al., LONG-TERM FOLLOW-UP OF ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA IN FIRST REMISSION AFTER CYCLOPHOSPHAMIDE TOTAL-BODY IRRADIATION AND CYCLOSPORINE, British Journal of Haematology, 93, 1996, pp. 257-257
SALVAGE TREATMENT WITH VAMP C-VAMP INFUSIONAL CHEMOTHERAPY AND HIGH-DOSE MELPHALAN IN REFRACTORY MYELOMAS
Authors: RAJE N POWLES R HORTON CAP MILAN S MIDDLETON G EISEN T VINER C TRELEAVEN J CUNNINGHAM D
Citation: N. Raje et al., SALVAGE TREATMENT WITH VAMP C-VAMP INFUSIONAL CHEMOTHERAPY AND HIGH-DOSE MELPHALAN IN REFRACTORY MYELOMAS, British Journal of Haematology, 93, 1996, pp. 303-303
AUTOGRAFTING IN MYELOMA PATIENTS WITH RENAL IMPAIRMENT
Authors: RAJE N POWLES R MILAN S MIDDLETON G EISEN T MEHTA J SINGHAL S TRELEAVEN J
Citation: N. Raje et al., AUTOGRAFTING IN MYELOMA PATIENTS WITH RENAL IMPAIRMENT, British Journal of Haematology, 93, 1996, pp. 304-304
A RANDOMIZED TRIAL OF SHORT-COURSE CONSOLIDATION CHEMOTHERAPY FOLLOWING HIGH-DOSE CHEMOTHERAPY IN MULTIPLE-MYELOMA
Authors: RAJE N POWLES R EISEN T MIDDLETON G FIELD M MEHTA J SINGHAL S TRELEAVEN J MILAN S
Citation: N. Raje et al., A RANDOMIZED TRIAL OF SHORT-COURSE CONSOLIDATION CHEMOTHERAPY FOLLOWING HIGH-DOSE CHEMOTHERAPY IN MULTIPLE-MYELOMA, British Journal of Haematology, 93, 1996, pp. 305-305
DEFIBROTIDE FOR REFRACTORY THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AFTER BONE-MARROW TRANSPLANTATION
Authors: HAMBLIN M POWLES R TRELEAVEN J SASO R SINGHAL S MIDDLETON G KULKARNI S CABRAL S MEHTA J
Citation: M. Hamblin et al., DEFIBROTIDE FOR REFRACTORY THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AFTER BONE-MARROW TRANSPLANTATION, Blood, 88(10), 1996, pp. 2966-2966
Risultati: 1-25 | 26-49